Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-26

Clinical Trial Update: The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for a combination of cephalexin and amoxicillin-clavulanate in pulmonary tuberculosis (BLAST-1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cephalexin (Cephalexin)
  • amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Western Sydney Local Health District | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: UNKNOWN